Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes
Aims/hypothesis: In type 1 diabetes, cardiovascular disease (CVD) and diabetic nephropathy progress in parallel, thereby potentiating the risk of premature death during their development. Since urinary liver-type fatty acid binding protein (L-FABP) predicts the progression of diabetic nephropathy, t...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
10 June 2017
|
| In: |
Diabetologia
Year: 2017, Jahrgang: 60, Heft: 9, Pages: 1782-1790 |
| ISSN: | 1432-0428 |
| DOI: | 10.1007/s00125-017-4328-x |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00125-017-4328-x Verlag, Volltext: https://doi.org/10.1007/s00125-017-4328-x 
|
| Verfasserangaben: | Nicolae M. Panduru, Carol Forsblom, Markku Saraheimo, Lena M. Thorn, Daniel Gordin, Nina Elonen, Valma Harjusalo, Angelika Bierhaus, Per M. Humpert, Per-Henrik Groop, on behalf of the FinnDiane Study Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 158060546X | ||
| 003 | DE-627 | ||
| 005 | 20230427065706.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180903s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00125-017-4328-x |2 doi | |
| 035 | |a (DE-627)158060546X | ||
| 035 | |a (DE-576)51060546X | ||
| 035 | |a (DE-599)BSZ51060546X | ||
| 035 | |a (OCoLC)1341017876 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Panduru, Nicolae |e VerfasserIn |0 (DE-588)115445746X |0 (DE-627)1015752373 |0 (DE-576)501009957 |4 aut | |
| 245 | 1 | 0 | |a Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes |c Nicolae M. Panduru, Carol Forsblom, Markku Saraheimo, Lena M. Thorn, Daniel Gordin, Nina Elonen, Valma Harjusalo, Angelika Bierhaus, Per M. Humpert, Per-Henrik Groop, on behalf of the FinnDiane Study Group |
| 264 | 1 | |c 10 June 2017 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.09.2018 | ||
| 520 | |a Aims/hypothesis: In type 1 diabetes, cardiovascular disease (CVD) and diabetic nephropathy progress in parallel, thereby potentiating the risk of premature death during their development. Since urinary liver-type fatty acid binding protein (L-FABP) predicts the progression of diabetic nephropathy, the aim of this study was to investigate whether urinary L-FABP also predicts cardiovascular outcomes and mortality.MethodsWe tested our hypothesis in a Finnish cohort of 2329 individuals with type 1 diabetes and a median follow-up of 14.1 years. The L-FABP to creatinine ratio was determined from baseline urine samples. The predictive value of urinary L-FABP was evaluated using Cox regression models, while its added predictive benefit for cardiovascular outcomes and mortality was evaluated using a panel of statistical indexes.ResultsUrinary L-FABP predicted incident stroke independently of traditional risk factors (HR 1.33 [95% CI 1.20, 1.49]) and after further adjustment for eGFR (HR 1.28 [95% CI 1.14, 1.44]) or AER (HR 1.24 [95% CI 1.06, 1.44]). In addition, it predicted mortality independently of traditional risk factors (HR 1.34 [95% CI 1.24, 1.45]), and after adjustment for eGFR (HR 1.29 [95% CI 1.18, 1.39]) or AER (HR 1.22 [95% CI 1.09, 1.36]). Urinary L-FABP was as good a predictor as eGFR or AER, and improved the AUC for both outcomes on top of traditional risk factors, with no reclassification benefit (integrated discrimination improvement/net reclassification improvement) for stroke or mortality when AER or eGFR were added to traditional risk factors. However, urinary L-FABP was not a predictor of other cardiovascular endpoints (coronary artery disease, peripheral vascular disease and overall CVD events) when adjusted for the AER.Conclusions/interpretationUrinary L-FABP is an independent predictor of stroke and mortality in individuals with type 1 diabetes. | ||
| 650 | 4 | |a Cardiovascular disease | |
| 650 | 4 | |a Diabetic complications | |
| 650 | 4 | |a Liver-type fatty acid binding protein | |
| 650 | 4 | |a Mortality | |
| 650 | 4 | |a Stroke | |
| 650 | 4 | |a Type 1 diabetes | |
| 650 | 4 | |a Urinary biomarkers | |
| 650 | 4 | |a Urinary L-FABP | |
| 700 | 1 | |a Bierhaus, Angelika |d 1962-2012 |e VerfasserIn |0 (DE-588)1038392292 |0 (DE-627)757235271 |0 (DE-576)175591814 |4 aut | |
| 700 | 1 | |a Humpert, Per Magnus |d 1974- |e VerfasserIn |0 (DE-588)122530748 |0 (DE-627)705941531 |0 (DE-576)293310181 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetologia |d Berlin : Springer, 1965 |g 60(2017), 9, Seite 1782-1790 |h Online-Ressource |w (DE-627)253722209 |w (DE-600)1458993-X |w (DE-576)072372354 |x 1432-0428 |7 nnas |a Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes |
| 773 | 1 | 8 | |g volume:60 |g year:2017 |g number:9 |g pages:1782-1790 |g extent:9 |a Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00125-017-4328-x |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00125-017-4328-x |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180903 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 122530748 |a Humpert, Per Magnus |m 122530748:Humpert, Per Magnus |d 50000 |e 50000PH122530748 |k 0/50000/ |p 9 | ||
| 998 | |g 1038392292 |a Bierhaus, Angelika |m 1038392292:Bierhaus, Angelika |d 50000 |e 50000PB1038392292 |k 0/50000/ |p 8 | ||
| 999 | |a KXP-PPN158060546X |e 3024322817 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Nicolae M. Panduru, Carol Forsblom, Markku Saraheimo, Lena M. Thorn, Daniel Gordin, Nina Elonen, Valma Harjusalo, Angelika Bierhaus, Per M. Humpert, Per-Henrik Groop, on behalf of the FinnDiane Study Group"]},"physDesc":[{"extent":"9 S."}],"note":["Gesehen am 03.09.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"10 June 2017","dateIssuedKey":"2017"}],"recId":"158060546X","language":["eng"],"title":[{"title":"Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes","title_sort":"Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes"}],"id":{"doi":["10.1007/s00125-017-4328-x"],"eki":["158060546X"]},"relHost":[{"id":{"issn":["1432-0428"],"zdb":["1458993-X"],"eki":["253722209"]},"disp":"Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetesDiabetologia","part":{"issue":"9","extent":"9","pages":"1782-1790","year":"2017","volume":"60","text":"60(2017), 9, Seite 1782-1790"},"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 27. November 2017","Ungezählte Beil.: Supplement"],"origin":[{"publisher":"Springer","dateIssuedKey":"1965","dateIssuedDisp":"1965-","publisherPlace":"Berlin ; Heidelberg"}],"corporate":[{"display":"European Association for the Study of Diabetes","role":"isb","roleDisplay":"Herausgebendes Organ"}],"language":["eng"],"recId":"253722209","title":[{"subtitle":"journal of the European Association for the Study of Diabetes (EASD)","title_sort":"Diabetologia","title":"Diabetologia"}],"pubHistory":["1.1965/66 -"]}],"person":[{"roleDisplay":"VerfasserIn","role":"aut","family":"Panduru","given":"Nicolae","display":"Panduru, Nicolae"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Bierhaus","given":"Angelika","display":"Bierhaus, Angelika"},{"display":"Humpert, Per Magnus","family":"Humpert","given":"Per Magnus","roleDisplay":"VerfasserIn","role":"aut"}]} | ||
| SRT | |a PANDURUNICURINARYLIV1020 | ||